Ahmad Rizal Ganiem

Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial

Rovina Ruslami, Ahmad Rizal Ganiem, Sofiati Dian et al. · The Lancet Infectious Diseases · 2012 · 343 citations

Pulmonary Tuberculosis, Health Sciences, Clinical Infection +9

Clinical Parameters, Routine Inflammatory Markers, and LTA4H Genotype as Predictors of Mortality Among 608 Patients With Tuberculous Meningitis in Indonesia

Arjan van Laarhoven, Sofiati Dian, Carolien Ruesen et al. · The Journal of Infectious Diseases · 2017 · 111 citations

Improving the microbiological diagnosis of tuberculous meningitis: A prospective, international, multicentre comparison of conventional and modified Ziehl–Neelsen stain, GeneXpert, and culture of cerebrospinal fluid

A Dorothee Heemskerk, Joseph Donovan, Do Dang Anh Thu et al. · Journal of Infection · 2018 · 109 citations · Full text

Cerebral tryptophan metabolism and outcome of tuberculous meningitis: an observational cohort study

Arjan van Laarhoven, Sofiati Dian, Raúl Aguirre‐Gamboa et al. · The Lancet Infectious Diseases · 2018 · 108 citations · Full text

Medicine, Cerebral Tryptophan Metabolism, Tuberculosis +5

Double-Blind, Randomized, Placebo-Controlled Phase II Dose-Finding Study To Evaluate High-Dose Rifampin for Tuberculous Meningitis

Sofiati Dian, Vycke Yunivita, Ahmad Rizal Ganiem et al. · Antimicrobial Agents and Chemotherapy · 2018 · 96 citations · Full text